Affordable Access

Publisher Website

Biomarkers of Alzheimer's disease in body fluids.

Authors
Type
Published Article
Journal
Science China. Life sciences
Publication Date
Volume
53
Issue
4
Pages
490–496
Identifiers
DOI: 10.1007/s11427-010-0081-9
PMID: 20596916
Source
Medline

Abstract

Various innovative diagnostic methods for Alzheimer's disease (AD) have been developed in view of the increasing prevalence and consequences of later-life dementia. Biomarkers in cerebrospinal fluid (CSF) and blood for AD are primarily based on the detection of components derived from amyloid plaques and neurofibrillary tangles (NFTs). Published reports on CSF and blood biomarkers in AD indicate that although biomarkers in body fluids may be utilized in the clinical diagnosis of AD, there are no specific markers that permit accurate and reliable diagnosis of early-stage AD or the monitoring of disease progression.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments